Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction.

A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

A medication currently used to treat diabetes and obesity may offer a new way to help people struggling with alcohol addiction. A recent study published in eBioMedicine found that the drug tirzepatide ...

With Alcohol and Opioid Cases Rising, Bright Paths Recovery Highlights the Need for Safe Detox and Inpatient Treatment ...

Addiction has causes that are neurobiological, psychological and structural. Treating these drivers is as important as managing the initial withdrawal. Medically managed withdrawal does not restore ...

In this group, we explore topics that include relapse prevention skill development, interpersonal effectiveness, managing high risk situations/triggers, boundaries, action planning and more. We ...

Substance abuse treatment is often overlooked in oncological care, despite its impact on cancer outcomes. Many cancer patients continue hazardous drinking during treatment, increasing risks of ...

WALKING away from any kind of addiction is not easy as it requires the concerned person to fully commit to the quitting ...

WhiteSands Alcohol & Drug Rehab Tampa has released a new educational resource focused on explaining “how inpatient alcohol rehabilitation programs are evaluated and selected within Florida’s treatment ...